Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma
- 28 April 2020
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 22 (8), 1366-1373
- https://doi.org/10.1038/s41436-020-0801-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanomaOncotarget, 2015
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014
- The Somatic Genomic Landscape of Chromophobe Renal Cell CarcinomaCancer Cell, 2014
- Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNAClinical Cancer Research, 2014
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human MalignanciesScience Translational Medicine, 2014
- voom: precision weights unlock linear model analysis tools for RNA-seq read countsGenome Biology, 2014
- Comprehensive molecular characterization of clear cell renal cell carcinomaNature, 2013
- Integrative genomics viewerNature Biotechnology, 2011
- A scaling normalization method for differential expression analysis of RNA-seq dataGenome Biology, 2010
- Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non–Small Cell Lung CancerClinical Cancer Research, 2010